A Safety and Efficacy Study of FCR001 vs Standard of Care in de Novo Living Donor Kidney Transplantation
Condition: Transplanted Organ Rejection Intervention: Biological: FCR001 Sponsor: Talaris Therapeutics Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Kidney Transplant | Kidney Transplantation | Research | Study | Transplants | Urology & Nephrology